Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety comparison of QMF Twisthaler versus mometasone furoate Twisthaler in persistent asthma
2009-011539-10Phase 2Completed
- Sponsor
- Novartis
- Start
- Jun 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of indacaterol + mometasone furoate and mometasone in persistent asthma (2 arms), sponsored by Novartis. Primary endpoints: Time to first serious asthma exacerbation and Rate of serious asthma exacerbations. Started Jun 2009; status: completed.
02
Drugs
indacaterol + mometasone furoatemometasone
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2009-011539-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011539-10.